Growth Hormone Deficiency in Children Completed Phase 1 Trials for Somatotropin (DB00052)

IndicationStatusPhase
DBCOND0034025 (Growth Hormone Deficiency in Children)Completed1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01973244A Trial Investigating Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of a Single Dose of Long-acting Growth Hormone (Somapacitan) Compared to Daily Dosing of Norditropin® SimpleXx® in Children With Growth Hormone DeficiencyTreatment